The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects tiny ...
Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...
Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...
The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying.
Using a single blood sample, multi-cancer early detection (MCED) tests screen for numerous types of cancers, including breast, ovarian, colorectal, pancreatic and prostate cancers. Trials are underway ...
MENLO PARK, Calif., Oct. 17, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that positive ...
ST. LOUIS — Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is looking for participants in a national trial for a multi-cancer detection test, which looks for signs of cancer in ...
PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (GH), a leading precision oncology company, today announced that its Shield multi-cancer detection (MCD) test has been granted Breakthrough ...
A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...
Discover Magazine on MSN
A Cancer Blood Test Shows Promise — But Is it the Breakthrough Clinicians Were Waiting For?
Learn more about a new cancer blood test that increases cancer detection multifold and what its limitations are.
MADISON, Wis., September 10, 2025 — Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...
(RTTNews) - Exact Sciences Corp. (EXAS) announced the U.S. launch of Cancerguard™, its multi-cancer early detection or MCED blood test, now available as a laboratory-developed test or LDT. Cancerguard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback